Kim, J. H., & Cheon, J. H. (2016). Understanding the Role of Adalimumab in the Treatment of Moderately to Severely Active Ulcerative Colitis. Gut Liver.
Chicago ZitierstilKim, Jae Hyun, und Jae Hee Cheon. "Understanding the Role of Adalimumab in the Treatment of Moderately to Severely Active Ulcerative Colitis." Gut Liver 2016.
MLA ZitierstilKim, Jae Hyun, und Jae Hee Cheon. "Understanding the Role of Adalimumab in the Treatment of Moderately to Severely Active Ulcerative Colitis." Gut Liver 2016.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.